Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Anxiety | 1 |
| Behavior Disorders | 1 |
| Clinical Diagnosis | 1 |
| Disability Identification | 1 |
| Drug Therapy | 1 |
| Foreign Countries | 1 |
| Mental Disorders | 1 |
| Mental Retardation | 1 |
| Patients | 1 |
| Severity (of Disability) | 1 |
| Standards | 1 |
| More ▼ | |
Source
| Journal of Intellectual… | 1 |
Author
| Barnes, T. | 1 |
| Bhaumik, S. | 1 |
| Flynn, A. | 1 |
| Hardy, S. | 1 |
| McIntyre, S. | 1 |
| Paton, C. | 1 |
| Rasmussen, J. | 1 |
| Shingleton-Smith, A. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| United Kingdom | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkPaton, C.; Flynn, A.; Shingleton-Smith, A.; McIntyre, S.; Bhaumik, S.; Rasmussen, J.; Hardy, S.; Barnes, T. – Journal of Intellectual Disability Research, 2011
Background: Antipsychotics are perceived to be over-used in the management of behavioural problems in people with an intellectual disability (ID). Published guidelines have set good practice standards for the use of these drugs for behavioural indications. We sought to identify the range of indications for which antipsychotic drugs are prescribed…
Descriptors: Standards, Severity (of Disability), Mental Retardation, Mental Disorders
